» Articles » PMID: 8174993

Serotonergic Mediation of Postprandial Colonic Tonic and Phasic Responses in Humans

Overview
Journal Gut
Specialty Gastroenterology
Date 1994 Apr 1
PMID 8174993
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

This study examined the hypothesis that 5HT3 mechanisms mediate the postprandial gastrocolonic response in humans. Fasting and postprandial colonic tone and motility were studied in 12 healthy volunteers and the effects of a selective 5HT3 antagonist, ondansetron assessed in a double blind, randomised, placebo controlled fashion. A manometry barostat assembly was positioned in the transverse or descending colon to quantitate contractile activity fasting, after drug infusion and postprandially after a 1000 kcal meal. Fasting colonic tone and motility indices were similar in the placebo and ondansetron groups; ondansetron did not affect fasting motility. The placebo group showed a significant reduction in barostat balloon volume (signifying increased tone) from 232 ml (median, interquartile range (IQR) 179-261) during fasting to 181 ml (median, IQR 128-208) (postprandially) (p = 0.02). In contrast, the ondansetron group did not have a tonic colonic response (median 248 ml (IQR 199-300) fasting to median, 226 ml (IQR 185-290) postprandially) after the meal. Phasic volume events measured by the barostat increased postprandially in both groups. Postprandial motor activity measured by manometry increased significantly in the placebo group, but not in the ondansetron group. In conclusion, a 5HT3 mechanism participates in the physiological contractile responses in the human transverse and descending colon after ingestion of a high energy meal.

Citing Articles

International Union of Basic and Clinical Pharmacology. CX. Classification of Receptors for 5-hydroxytryptamine; Pharmacology and Function.

Barnes N, Ahern G, Becamel C, Bockaert J, Camilleri M, Chaumont-Dubel S Pharmacol Rev. 2020; 73(1):310-520.

PMID: 33370241 PMC: 7770494. DOI: 10.1124/pr.118.015552.


Lack of an Effect of Gastric Capsaicin on the Rectal Component of the Gastrocolonic Response.

Fuhrer M, Hammer J Dig Dis Sci. 2017; 62(12):3542-3549.

PMID: 29086328 DOI: 10.1007/s10620-017-4822-5.


Pharmacologic Agents for Chronic Diarrhea.

Lee K Intest Res. 2015; 13(4):306-12.

PMID: 26576135 PMC: 4641856. DOI: 10.5217/ir.2015.13.4.306.


Novel therapeutic agents in neurogastroenterology: advances in the past year.

Camilleri M Neurogastroenterol Motil. 2014; 26(8):1070-8.

PMID: 24953086 PMC: 4107107. DOI: 10.1111/nmo.12386.


Effects of 5-HT2B, 5-HT3 and 5-HT4 receptor antagonists on gastrointestinal motor activity in dogs.

Morita H, Mochiki E, Takahashi N, Kawamura K, Watanabe A, Sutou T World J Gastroenterol. 2013; 19(39):6604-12.

PMID: 24151388 PMC: 3801375. DOI: 10.3748/wjg.v19.i39.6604.


References
1.
Dapoigny M, Cowles V, Zhu Y, Condon R . Vagal influence on colonic motor activity in conscious nonhuman primates. Am J Physiol. 1992; 262(2 Pt 1):G231-6. DOI: 10.1152/ajpgi.1992.262.2.G231. View

2.
Tonini M, Rizzi C, Manzo L, Onori L . Novel enteric 5-HT4 receptors and gastrointestinal prokinetic action. Pharmacol Res. 1991; 24(1):5-14. DOI: 10.1016/1043-6618(91)90059-7. View

3.
Loeb D, Talley N, Ahlquist D, CARPENTER H, Zinsmeister A . Long-term nonsteroidal anti-inflammatory drug use and gastroduodenal injury: the role of Helicobacter pylori. Gastroenterology. 1992; 102(6):1899-905. DOI: 10.1016/0016-5085(92)90311-l. View

4.
Picon L, Lemann M, Flourie B, Rambaud J, Rain J, Jian R . Right and left colonic transit after eating assessed by a dual isotopic technique in healthy humans. Gastroenterology. 1992; 103(1):80-5. DOI: 10.1016/0016-5085(92)91098-o. View

5.
Steadman C, Talley N, Phillips S, Zinsmeister A . Selective 5-hydroxytryptamine type 3 receptor antagonism with ondansetron as treatment for diarrhea-predominant irritable bowel syndrome: a pilot study. Mayo Clin Proc. 1992; 67(8):732-8. DOI: 10.1016/s0025-6196(12)60797-6. View